Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of ReadyPrep CHG Cloth
NCT03331263Phase 1Completed
- Sponsor
- Medline
- Start
- Jul 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of chlorhexidine in surgical site infection (SSI) (3 arms), sponsored by Medline. Primary endpoint: Plasma Levels of Chlorhexidine Following Systemic Exposure at 24 hours. Started Jul 2017; status: completed.
02
Drugs
chlorhexidine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03331263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331263.